Chris Storgard - Net Worth and Insider Trading
Chris Storgard Net Worth
The estimated net worth of Chris Storgard is at least $111,106 dollars as of 2024-11-13. Chris Storgard is the Chief Medical Officer of Fate Therapeutics Inc and owns about 46,683 shares of Fate Therapeutics Inc (FATE) stock worth over $111,106. Details can be seen in Chris Storgard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chris Storgard has not made any transactions after 2016-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chris Storgard
Chris Storgard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chris Storgard owns 1 companies in total, including Fate Therapeutics Inc (FATE) .
Click here to see the complete history of Chris Storgard’s form 4 insider trades.
Insider Ownership Summary of Chris Storgard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FATE | Fate Therapeutics Inc | 2016-11-23 | Chief Medical Officer |
Chris Storgard Latest Holdings Summary
Chris Storgard currently owns a total of 1 stock. Chris Storgard owns 46,683 shares of Fate Therapeutics Inc (FATE) as of November 23, 2016, with a value of $111,106.
Latest Holdings of Chris Storgard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | 2016-11-23 | 46,683 | 2.38 | 111,106 |
Holding Weightings of Chris Storgard
Chris Storgard Form 4 Trading Tracker
According to the SEC Form 4 filings, Chris Storgard has made a total of 0 transactions in Fate Therapeutics Inc (FATE) over the past 5 years. The most-recent trade in Fate Therapeutics Inc is the acquisition of 37,593 shares on November 23, 2016, which cost Chris Storgard around $99,997.
Insider Trading History of Chris Storgard
- 1
Chris Storgard Trading Performance
GuruFocus tracks the stock performance after each of Chris Storgard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chris Storgard is 22.19%. GuruFocus also compares Chris Storgard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chris Storgard within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chris Storgard's insider trading performs compared to the benchmark.
Performance of Chris Storgard
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.98 | | | | | |
| Relative Return to S&P 500(%) | -16.66 | | | | | |
Chris Storgard Ownership Network
Ownership Network List of Chris Storgard
Ownership Network Relation of Chris Storgard
Chris Storgard Owned Company Details
What does Fate Therapeutics Inc do?
Who are the key executives at Fate Therapeutics Inc?
Chris Storgard is the Chief Medical Officer of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .
Fate Therapeutics Inc (FATE) Insider Trades Summary
Over the past 18 months, Chris Storgard made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 18,777 shares made by Dulac Edward J Iii , a net sale of 4,725 shares made by Yuan Xu , and a net sale of 35,237 shares made by Cindy Tahl .
In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.
Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fate Therapeutics Inc Insider Transactions
Chris Storgard Mailing Address
Above is the net worth, insider trading, and ownership report for Chris Storgard. You might contact Chris Storgard via mailing address: C/o Fate Therapeutics, Inc., 3535 General Atomics Court, Ste 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
